Research

Research Currently Underway at The Research Institute at Lindner Center of HOPE Could Lead to the Development of the First Diagnostic Test for People Struggling with Depressive Symptoms

The Research Institute at Lindner Center of HOPE is a site for an open label study with the primary goal of validating a signature (model) based on a panel of serum proteomic markers that discriminate Bipolar I, Bipolar II and Major Depression in people seeking treatment for a major depressive episode. The success of this […]

Research Institute at Lindner Center of HOPE to Test Medication for Intermittent Explosive Disorder (IED) Treatment

By mid-August Lindner Center of HOPE researchers anticipate recruiting for a new medication trial that could impact the treatment of Intermittent Explosive Disorder (IED). IED, characterized by an inability to resist aggressive urges and explosive outbursts, affects six percent of the general population with no designated medications currently available for treatment. The exploratory Phase II […]

Miles in Memory of Kathy to Benefit Mood Disorders Research at Lindner Center of HOPE

Husband to ride bike from Lindner Center of HOPE to Yellowstone National Park to Memorialize Wife’s Struggle with Depression Kathy Klausing was loyal and devoted to her family. Sadly, her struggles with depression plagued her until her death in November 2014. Kathy’s husband of 28 years, Jack, misses her every day and wanted to do […]

Touchdown for HOPE Raises $203,000 for Bipolar and Mood Disorders Research

The sixth annual Touchdown for HOPE Super Bowl Sunday event took place on February 1, 2015 at the Great American Ballpark Champions Club. With 423 attendees and $203,000 raised to enhance Bipolar and Mood Disorders Research at Lindner Center of HOPE, The Best Super Bowl Party in Town was a huge success. Great American Ballpark […]

Lindner Center’s Dr. McElroy Investigates Experimental Drug to Treat Depression

Lindner Center of HOPE’s Chief Research Officer, Dr. Susan McElroy, was recently cited in a Forbes article about her work in the investigation of an experimental drug that could be used in the treatment of depression. Naurex, a private company founded by a Northwestern University professor in Evanston, Ill., is reporting that this experimental drug works to help push patients out […]

Clinical Trial Examines Safety, Effectiveness of Drug to Treat Binge Eating Disorder

Susan L. McElroy, MD, Chief Research Officer, Lindner Center of HOPE, co-authored study published online by Jama Psychiatry At some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients with binge-eating disorder (BED), a public health problem associated symptoms of […]

Lindner Center of HOPE’s President and CEO Named Amongst Highly Cited Researchers

Mason, OH, November 19, 2014 – Lindner Center of HOPE’s President and CEO, Dr. Paul E. Keck, Jr., was named amongst Thomson Reuters Highly Cited Researchers, a listing of the world’s leading scholars in the sciences and social sciences, in honor of his landmark contributions to research in the field of Psychiatry/Psychology. Thomson Reuters, evaluates […]

Lead Investigator, Dr. Susan McElroy: Positive Top-line Results Shown for Vyvanse® Capsules in Adults with Binge Eating Disorder

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com Positive Top-line Results Shown for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) in Adults with Binge Eating Disorder Shire Plans to Submit a Supplemental New Drug Application (sNDA) by Q3 2014 05 November 2013 – Shire plc (LSE: SHP, NASDAQ: SHPG) […]